What does flat-rate tirzepatide pricing mean?
A plain-language explainer of flat-rate (dose-independent) pricing, how it differs from dose-tiered pricing, and when each one saves you money.
Flat-rate, defined
Flat-rate (dose-independent) compounded tirzepatide pricing is a model where you pay the same monthly price regardless of your prescribed dose — whether your clinician has you at 2.5 mg or 15 mg weekly. This contrasts with dose-tiered pricing, where the monthly cost rises as the dose increases.
Why the model matters more than month one
Tirzepatide is titrated. You generally start low and step up over weeks to months. Under a dose-tiered plan, your bill rises as you climb; under a flat-rate plan it doesn't. A $279 dose-tiered intro that becomes $499 at maintenance can cost more across a year than a $186–$215 flat rate that never moves. Compare providers on the flat-rate providers page.
Questions to ask any provider
Before enrolling, ask: Is the price the same at every dose? What's included (visits, labs, shipping)? What happens to the price if I titrate up? What is the cancellation policy?
Questions
Does flat-rate pricing mean the medication is cheaper?
Not necessarily at the start. Flat-rate means the price doesn't change as your dose increases. Its advantage shows up over a full treatment course and at higher maintenance doses.
Do all compounded tirzepatide providers use flat-rate pricing?
No. Some are flat-rate (one price across all doses), others are dose-tiered (price rises with dose). Confirm a provider's current model before enrolling.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved.